Therefore, the role and mechanisms of TRAF3IP2-AS1 in Xp11.2 tRCC need to be addressed, which may provide therapeutic and prognostic value for Xp11.2 tRCC. Here, TRAF3IP2 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.